论文部分内容阅读
目的探讨胺碘酮治疗急诊冠状动脉粥样硬化性心脏病快速心律失常患者的临床效果。方法选取2014年8月至2015年2月沈阳急救中心收治的急诊冠状动脉粥样硬化性心脏病快速心律失常患者60例为研究对象,按随机数字表法分为观察组与对照组,每组30例。观察组患者给予胺碘酮治疗,对照组患者给予利多卡因治疗,比较两组患者的治疗效果。结果观察组患者总有效率为93.3%,显著高于对照组的66.7%,差异有统计学意义(P<0.05);观察组不良反应发生率为6.7%,低于对照组的33.3%,差异有统计学意义(P<0.05)。结论胺碘酮治疗急诊冠状动脉粥样硬化性心脏病快速心律失常患者的临床效果显著。
Objective To investigate the clinical effect of amiodarone in the treatment of patients with acute arrhythmia of coronary atherosclerotic heart disease. Methods Sixty patients with acute coronary arrhythmia patients with acute cardiac arrhythmia who were admitted to Shenyang Emergency Center from August 2014 to February 2015 were selected as study objects and divided into observation group and control group according to random number table method. 30 cases. Patients in the observation group were treated with amiodarone, while those in the control group were treated with lidocaine. The therapeutic effect was compared between the two groups. Results The total effective rate of the observation group was 93.3%, significantly higher than that of the control group (66.7%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 6.7%, which was lower than that of the control group (33.3% There was statistical significance (P <0.05). Conclusions Amiodarone has a significant clinical effect in the treatment of patients with acute coronary arrhythmia and coronary heart disease.